Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AutoGenomics, Inc.
AutoGenomics, Inc. Files Registration Statement for Initial Public Offering
August 10th, 2008
AutoGenomics, Inc. announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to the proposed initial public offering of shares of its common stock. The number of shares of common stock to be offered, all of which are expected to be offered by AutoGenomics, Inc., and the price range for the offering, have not yet been determined. J.P. Morgan Securities Inc. is acting as sole book-running manager of the offering, and Deutsche Bank Securities Inc. is acting as co-lead manager. Pacific Growth Equities, LLC and Robert W. Baird & Co. Incorporated are acting as co-managers. The offering will be...
Source: Pharma Investments, Ventures & Law Weekly (2008-08-10)
|
